Future Science Group
OCTalks: monitoring MRD in hematological malignancy management
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:03
- More information
Informações:
Synopsis
In this interview we explore what minimal residual disease (MRD) is in hematological malignancies and how MRD is currently monitored. The interviewees also explain their recent research published in Nanomedicine, which investigates a novel tool to monitor hematological malignancies.
